Prevention of serogroup B meningococcal disease

The Lancet

Volumn 379, Issue 9816, 2012, Pages 592-594

  Stephens, David S ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; PLACEBO;

BACTERIAL TRANSMISSION; CLINICAL PRACTICE; DRUG EFFICACY; DRUG SAFETY; GENETIC HETEROGENEITY; HISPANIC; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; JUVENILE RHEUMATOID ARTHRITIS; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NOTE; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT; VACCINATION;

EID: 84857235875     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61934-X     Document Type: Note

References (10)

1. ME Santolaya, M O'Ryan, MT Valenzuela for the V72P10 Meningococcal B Adolescent Vaccine Study group Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study Lancet 2012 10.1016/S0140-6736(11)61713-3 published online Jan 18.
2. E Miller, D Salisbury, M Ramsay Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story Vaccine 20 suppl 1 2001 S58 S67
3. R Gasparini, D Panatto Meningococcal glycoconjugate vaccines Hum Vaccin 7 2011 170 182
4. NE Rosenstein, BA Perkins, DS Stephens, T Popovic, JM Hughes Meningococcal disease N Engl J Med 344 2001 1378 1388
5. DS Stephens, B Greenwood, P Brandizaeg Epidemic meningitis, meningococcaemia, and Neisseria meningitidis Lancet 369 2007 2196 2210 (Pubitemid 46977462)
6. D Lennon, C Jackson, S Wong, M Horsfall, J Stewart, S Reid Fast tracking the vaccine licensure process to control an epidemic of serogroup B meningococcal disease in New Zealand Clin Infect Dis 49 2009 597 605
7. DS Stephens Outer-membrane-vesicle vaccines: old but not forgotten Lancet Infect Dis 11 2011 421 422
8. A Mascioni, BE Bentley, R Camarda et al. Structural basis for the immunogenic properties of the meningococcal vaccine candidate LP2086 J Biol Chem 284 2009 8738 8746
9. Boccadifuoco G, Donnelly J, Medini D, et al. Estimating the potential strain coverage in Europe of a multicomponent vaccine targeting serogroup B meningococci. Meningitis and Septicemia in Children and Adults Conference 2011. London, UK; Nov 8-9, 2011. Abstract V36.
10. MC Maiden, AB Ibarz-Pavon, R Urwin et al. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity J Infect Dis 197 2008 737 743 (Pubitemid 351364476)